Evidence map›Paper›PMID 41305519›Full record

ArticleViruses2025

Atomic Force Microscopy of Poliovirus Particles After Inactivation by Chemical Methods and Accelerated Electrons.

Sergey V Kraevsky, Sergey L Kanashenko, Alena V Kolesnichenko, Yury Yu Ivin, Anastasiia N Piniaeva, Anastasiya A Kovpak, Aydar A Ishmukhametov, Sergey V Budnik, Roman S Churyukin, Oleg A Shilov and 1 more

Abstract read
In one paragraph

Article in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sergey V KraevskyInstitute of Biomedical Chemistry, 10 Pogodinskaya Str., 119121 Moscow, Russia.ORCID 0000-0001-8062-6668
Sergey L KanashenkoInstitute of Biomedical Chemistry, 10 Pogodinskaya Str., 119121 Moscow, Russia.
Alena V KolesnichenkoInstitute of Biomedical Chemistry, 10 Pogodinskaya Str., 119121 Moscow, Russia.
Yury Yu IvinInstitute of Biomedical Chemistry, 10 Pogodinskaya Str., 119121 Moscow, Russia.ORCID 0000-0003-0995-7944
Anastasiia N PiniaevaInstitute of Biomedical Chemistry, 10 Pogodinskaya Str., 119121 Moscow, Russia.
Anastasiya A KovpakChumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis), 8/1 Moskovsky Settlement, Polio Institute Settlement, 108819 Moscow, Russia.ORCID 0000-0003-3200-763X
Aydar A IshmukhametovChumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis), 8/1 Moskovsky Settlement, Polio Institute Settlement, 108819 Moscow, Russia.
Sergey V BudnikTeocortex LLC, 34/6 Pervomaysky Settlement, 108808 Moscow, Russia.
Roman S ChuryukinTeocortex LLC, 34/6 Pervomaysky Settlement, 108808 Moscow, Russia.
Oleg A ShilovTeocortex LLC, 34/6 Pervomaysky Settlement, 108808 Moscow, Russia.
Dmitry D ZhdanovInstitute of Biomedical Chemistry, 10 Pogodinskaya Str., 119121 Moscow, Russia.ORCID 0000-0003-4753-7588

Funding

Russian Science Foundation 23-15-00471
6 · The paper itself

Abstract

The traditional method used in the production of inactivated vaccines is chemical inactivation using beta-propiolactone or formaldehyde. An alternative method is inactivation by irradiation. Virus inactivation is often accompanied by a change in particle shape, which can negatively affect the preservation of antigens and immunogenicity. Therefore, determining the shape and structure of the viral particle after inactivation is an important step in the development of antiviral vaccines. The poliovirus strain Sabin 2 was inactivated with a dose of 30.5 ± 0.5 kGy. in a pulsed linear electron accelerator with a power of 15 kW and electron energy of 10 MeV. Samples inactivated with beta-propiolactone or formaldehyde were used for comparison. All types of inactivation resulted in D-antigen recovery as determined by enzyme-linked immunosorbent assay. There was no statistical difference between D-antigen recovery in irradiated samples and those inactivated chemically. The shape and structure of the inactivated poliovirus particles were studied using atomic force and electron microscopy. After inactivation with beta-propiolactone or formaldehyde, a change in the native icosahedral shape was observed, with many particles appearing flattened. Specific sorption of antibodies showed that the antigen is mainly preserved in intact capsids for all type of inactivation. However, in the case of inactivation with formaldehyde and accelerated electrons, a significant number of fragments measuring 10-20 nm in height were present. Their proportion was 38 ± 2% and 17 ± 2% for inactivation with accelerated electrons and formaldehyde, respectively. The proportion of bound fragments during inactivation with beta-propiolactone was less than 1%.

Indexed as

ElectronsPoliovirusPoliovirus Vaccine, InactivatedVirionVirus InactivationFormaldehydeMicroscopy, Atomic ForcePropiolactoneFormaldehydePoliovirus Vaccine, InactivatedPropiolactoneatomic force microscopyinactivated oral vaccine strainsnon-infectious vaccine-like particles

Identifiers

PMID41305519
PMCPMC12656870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.